Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice

Journal of Immunology

Volumn 170, Issue 10, 2003, Pages 5219-5227

  McClellan, Sharon A ^b   Huang, Xi ^b   Barrett, Ronald P ^b   Van Rooijen, Nico ^b   Hazlett, Linda D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; LIPOSOME; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CELL COUNT; CHEMOTAXIS; CONTROLLED STUDY; CORNEA PERFORATION; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INFECTION CONTROL; INFLAMMATION; KERATITIS; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TREATMENT PLANNING;

EID: 0038560947     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.10.5219     Document Type: Article

References (51)

1. Laibson, P. R., F. T. Fraunfelder, and F. H. Roy. 1990. Pseudomonas aeruginosa. Saunders, Philadelphia, p. 35.
2. Hobden, J., S. Masinick, R. Barrett, and L. D. Hazlett. 1997. Proinflammatory cytokine deficiency and the pathogenesis of P. aeruginosa in aged mice. Infect. Immun. 65:2754.
3. Kernacki, K. A., D. J. Goebel, M. S. Poosch, and L. D. Hazlett. 1998. Early cytokine and chemokine gene expression during Pseudomonas aeruginosa corneal infection. Infect. Immun. 66:376.
4. Kernacki, K. A., R. Barrett, J. Hobden, and L. D. Hazlett. MIP-2 is a mediator of PMN influx in ocular bacterial infection. J. Immunol. 164:1037.
5. Hazlett, L. D. 2002. Pathogenic mechanisms of P. aeruginosa keratitis: a review of the role of T cells, Langerhans cells, PMN and cytokines. DNA Cell Biol. 21:383.
6. Kurpakus, M. A., K. A. Kernacki, and L. D. Hazlett. 1999. Corneal cell proteins and ocular surface pathology: a review. Biotech. Histochem. 74:146.
7. Rudner, X. L., K. A. Kernacki, R. P. Barrett, and L. D. Hazlett. 2000. Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates MIP-2 production, PMN persistence and comeal perforation. J. Immunol. 164:6576.
8. + T cell chemotaxis and contributes to PMN persistence in P. aeruginosa comeal infection. J. Leukocyte Biol. 70:911.
9. Hazlett, L. D., X. L. Rudner, S. A. McClellan, R. P. Barrett, and S. Lighvani. 2002. IL-12 and IFN-γ in Pseudomonas aeruginosa corneal infection. Invest. Ophthalmol. Vis. Sci. 43:419.
10. Huang, X., S. McClellan, X. L. Rudner, R. Barrett, and L. D. Hazlett. 2002. IL-18 contributes to host resistance against infection with P. aeruginosa through induction of IFN-γ. J. Immunol. 168:5756.
11. Xue, M., M. D. P. Willcox, A. Lloyd, D. Wakefield, and A. Thakur. 2001. Regulatory effects of IL-1β on cytokine/chemokine production by human corneal epithelial cells during Pseudomonas aeruginosa colonization. Clin. Exp. Ophthalmol. 3:171.
12. Thakur, A., M. L. Xue, W. Wang, A. Lloyd, D. Wakefield, and M. D. P. Willcox. 2001. Expression of macrophage migration inhibitory factor (MIF) during Pseudomonas keratitis. Clin. Exp. Ophthalmol. 3:179.
13. Thakur, A., J. Kyd, M. Xue, M. D. P. Willcox, and A. Cripps. 2001. Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats. Infect. Immun. 69:3295.
14. Xue, M. L., H. Zhu, M. Willcox, Waklefiled D., A. Lloyd, and A. Thakur. 2001. The role of IL-1β in the regulation of IL-8 and IL-6 in human corneal epithelial cells during Pseudomonas aeruginosa colonization. Curr. Eye Res. 23:406.
15. Xue, M. L., A. Thakur, and M. Willcox. 2002. Gene expression of pro-inflammatory cytokines and chemokines in mouse eye infected with Pseudomonas aeruginosa. Clin. Exp. Ophthalmol. 30:196.
16. Thakur, A., M. Xue, F. Stapleton, A. R. Lloyd, D. Wakefield, and M. D. P. Willcox. 2002. Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis. Infect. Immun. 70:2187.
17. Xue, M. L., A. Thakur, and M. Willcox. 2002. Macrophage inflammatory protein-2 and vascular endothelial growth factor regulate corneal neovascularization induced by infection with Pseudomonas aeruginosa in mice. Immunol. Cell Biol. 80:323.
18. Hazlett, L. D., S. A. McClellan, R. Barrett, and X. L. Rudner. 2001. B7/CD28 co-stimulation is critical in susceptibility to Pseudomonas aeruginosa corneal infection: a comparative study using monoclonal antibody blockade and CD28-deficient mice. J. Immunol. 166:1282.
19. Hazlett, L. D., S. A. McClellan, X. L. Rudner, and R. P. Barrett. 2001. The role of Langerhans cells in P. aeruginosa infection. Invest. Ophthalmol. Vis. Sci. 43:189.
20. Kernacki, K. A., R. P. Barrett, S. M. McClellan, and L. D. Hazlett. 2000. Aging and PMN response to P. aeruginosa infection. Invest. Ophthalmol. Vis. Sci. 41:3019.
21. + T-cell-dependent keratitis with genetic susceptibility to P. aeruginosa ocular infection. J. Immunol. 159:6283.
22. Hazlett, L. D., S. A. McClellan, B. Kwon, and R. Barrett. 2000. Increased severity of P. aeruginosa comeal infection in strains of mice designated as Th1 vs Th2 responsive. Invest Ophthalmol. Vis. Sci. 41:805.
23. Claassen, I., N. van Rooijen, and E. Claassen. 1990. A new method for removal of mononuclear phagocytes from heterogeneous cell populations in vitro using the liposome-mediated macrophage "suicide" technique. J. Immunol. Methods 134:153.
24. Delemarre, F. G., N. Kors, G. Kraal, and N. van Rooijen. 1990. Repopulation of macrophages in popliteal lymph nodes of mice after liposome-mediated depletion. J. Leukocyte Biol. 47:251.
25. Qian, Q., M.A. Jutila, N. van Rooijen, and J. E. Cutler. 1994. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 152:5000.
26. van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanisms of action, preparation of liposomes and applications. J. Immunol. Methods 174:83.
27. van Rooijen, N., A. Sanders, and T. K. van den Berg. 1996. Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. J. Immunol. Methods 193:93.
28. Cheng H., T. M. Tumpey, H. F. Staats, N. van Rooijen, J. E. Oakes, and R. N. Lausch. 2000. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection. Invest. Ophthalmol. Vis. Sci. 41:1402.
29. Hazlett, L. D., M. M. Moon, M. Strejc, and R. S. Berk. 1987. Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Invest. Ophthalmol. Vis. Sci. 28:1978.
30. Tumpey, T. M., H. Cheng, X. T. Yan, J. E. Oakes, and R. N. Lausch. 1998. Chemokine synthesis in the HSV-1 infected cornea and its suppression by IL-10. J. Leukocyte Biol. 63:486.
31. Williams, R. N., C. A. Paterson, K. E. Eakins, and P. Bhattacherjee. 1983. Quantitation of ocular inflammation: evaluation of polymorphonuclear leukocyte inflammation by measuring myeloperoxidase activity. Curr. Eye Res. 2:465.
32. Roux, K. H. 1995. Optimization and troubleshooting in PCR. In PCR Primer: A Laboratory Manual. C. W. Diffenbach and G. S. Dveksler, eds. Cold Spring Harbor Lab. Press, Plainview, NY, p. 53.
33. Mills, C. D., K. Kinkaid, J. M. Alt, M. J. Heilman, and A. M. Hill. 2000. M-1/M2 macrophages and Th1/Th2 paradigm. J. Immunol. 164:6166.
34. North, R. J. 1978. The concept of the activated macrophage. J. Immunol. 121:806.
35. Adams, D. O., and T. A. Hamilton. 1984. The cell biology of macrophage activation. Annu. Rev. Immunol. 2:283.
36. Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Invest. 79:319.
37. Laskin, D. L., and K. J. Pendino. 1995. Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35:655.
38. Delgado M., E. J. Munoz-Elias, C. Martinez, R. P. Gomariz, and D. Ganea. 1999. VIP and PACAP38 modulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines. Ann. NY Acad. Sci. 897:401.
39. Liew, F. Y., Y. Li, D. Moss, C. Parkinson, M. V. Rogers, and S. Moncada. 1991. Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur. J. Immunol. 21:3009.
40. Oswald, I. P., S. Afroun, D. Bray, J. F. Petit, and G. Lemaire. 1992. Low response of BALB/c macrophages to priming and activating signals. J. Leukocyte Biol. 52:315.
41. Stenger, S. H., H. Thuring, M. Rollinghof, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase closely associated with resistance to Leishmania major. J. Exp. Med. 180:783.
42. Chakkalath, H. R., and R. G. Titus. 1994. Leismania major-parasitized macrophages augment Th2-type T cell activation. J. Immunol. 153:4378.
43. van Klink, F., W. M. Taylor, H. Alizadeh, M. J. Jager, N. van Rooijen, and J. Y. Niederkorn. 1996. The role of macrophages in Acanthamoeba keratitis. Invest. Ophthalmol. Vis. Sci. 37:1271.
44. Leemans, J. C., N. P. Juffermans, S. Florquin, N. van Rooijen, M. J. Vervoordeldonk, A. Verbon, S. J. H. van Deventer, and T. van der Poll. 2001. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J. Immunol. 166:4611.
45. Kodukula, P., T. Liu, N. van Rooijen, M. J. Jager, and R. L. Hendricks. 1999. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J. Immunol. 162:2895.
46. Kooguchi, K., S. Hashimoto, A. Kobayashi, Y. Kitamura, I. Kudoh, J. Weiner-Kronish, and T. Sawa. 1998. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect. Immun. 66:3164.
47. Shinohara, H., S. Yano, C. D. Bucana, I. J. Fidler. 2000. Induction of chemokine secretion and enhancement of contact dependent macrophage cytotoxicity by engineered expression of granulocyte-macrophage colony-stimulating factor in human colon cancer cells. J. Immunol. 164:2728.
48. Sapru K., P. K. Stotland, and M. M. Stevenson. 1999. Quantitative and qualitative differences in bronchoalveolar inflammatory cells in Pseudomonas aeruginosa-resistant and susceptible mice. Clin. Exp. Immunol. 115:103.
49. Wally, K. R., N. W. Lukas, T. J. Standiford, R. M. Strieter, and S. L. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64:4733.
50. Hunter, C. A., L. A. Ellis-Neyer, T. Slifer, S. Konaly, G. Grunig, M. Fort, D. Rennick, and F. G. Araujo. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158:3311.
51. Sawa, T., D. B. Corry, M. A. Gropper, M. Ohara, K. Kurahashi, and J. P. Weiner-Kronish. 1997. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J. Immunol. 159:2858.